Details for: VIMOVO
Company: XEDITON PHARMACEUTICALS INC
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02361701 | VIMOVO | NAPROXEN; ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) | 375 MG; 20 MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | ORAL |
02361728 | VIMOVO | NAPROXEN; ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) | 500 MG; 20 MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | ORAL |
Summary Reports
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.